Chemotherapy, Cancer, Regional Perfusion
"Chemotherapy, Cancer, Regional Perfusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part.
| Descriptor ID |
D010478
|
| MeSH Number(s) |
E02.319.267.200 E04.292.425
|
| Concept/Terms |
Chemotherapy, Cancer, Regional Perfusion- Chemotherapy, Cancer, Regional Perfusion
- Regional Perfusion Antineoplastic Chemotherapy
- Isolation Perfusion Cancer Chemotherapy
- Cancer Chemotherapy, Regional Perfusion
- Perfusion Cancer Chemotherapy, Regional
- Regional Perfusion Cancer Chemotherapy
|
Below are MeSH descriptors whose meaning is more general than "Chemotherapy, Cancer, Regional Perfusion".
Below are MeSH descriptors whose meaning is more specific than "Chemotherapy, Cancer, Regional Perfusion".
This graph shows the total number of publications written about "Chemotherapy, Cancer, Regional Perfusion" by people in this website by year, and whether "Chemotherapy, Cancer, Regional Perfusion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemotherapy, Cancer, Regional Perfusion" by people in Profiles.
-
Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases. J Surg Oncol. 2023 Apr; 127(5):831-840.
-
The impact of HIPEC vs. EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. Int J Hyperthermia. 2020; 37(1):1182-1188.
-
The Association of Tumor Laterality and Survival After Cytoreduction for Colorectal Carcinomatosis. J Surg Res. 2020 04; 248:20-27.
-
Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival. Ann Surg Oncol. 2018 Jul; 25(7):2018-2026.
-
Factors associated with palliative care use in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res. 2017 05 01; 211:79-86.
-
Hepatic Perfusion Therapy. Surg Clin North Am. 2016 Apr; 96(2):357-68.
-
Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol. 2014 Aug 21; 12:270.
-
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol. 2015 May; 22(5):1686-93.
-
Regional therapies for advanced cancer. Ann Surg Oncol. 2014 May; 21(5):1426-8.
-
The use of isolated limb infusion in limb threatening extremity sarcomas. Int J Hyperthermia. 2013; 29(1):1-7.